Parenteral Nutrition Market 2024: Industry Size, Growth Drivers, Trends, Analysis and Forecast by 2032
Parenteral Nutrition Market 2024: Industry Size, Growth Drivers, Trends, Analysis and Forecast by 2032
The global parenteral nutrition market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

The latest report by IMARC Group, titled “Parenteral Nutrition Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the parenteral nutrition market trends. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.

The global parenteral nutrition market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.

Parenteral Nutrition Market Trends:

The global market is primarily driven by the increasing prevalence of chronic diseases such as cancer, gastrointestinal disorders, and diabetes. Moreover, rising awareness among healthcare professionals and patients regarding the benefits of parenteral nutrition is fostering market expansion. Furthermore, the growing aging population, which is more susceptible to nutrient deficiencies, is contributing to market growth.

Additionally, advancements in healthcare infrastructure and technology are enhancing the efficiency and accessibility of parenteral nutrition therapies. Besides, an increase in premature births, requiring specialized nutrition, is driving demand in neonatal care. The rising adoption of home healthcare solutions further supports the market’s growth. Moreover, government initiatives aimed at improving healthcare access and quality, especially in developing regions, are propelling the market. The expansion of healthcare insurance coverage for parenteral nutrition treatments is facilitating its wider adoption across various demographics.   

Get a Sample Copy of this Report: https://www.imarcgroup.com/parenteral-nutrition-market/requestsample

Parenteral Nutrition Market Scope and Growth Analysis:

The scope of the market is broadening due to technological advancements in formulations and delivery methods that are improving the safety and efficacy of parenteral nutrition. The market’s scope is further broadened by the increasing focus on personalized healthcare, allowing tailored nutritional interventions for specific patient needs. The rising demand for specialized nutrition in intensive care units (ICUs) and neonatal care are broadening the market scope as well. The ongoing shift towards home healthcare services, supported by portable and user-friendly parenteral nutrition systems, is also adding to the market’s growth.

Furthermore, the expansion of healthcare services in emerging markets and growing healthcare expenditures are enabling wider access to parenteral nutrition, thereby enhancing market potential. Expanding clinical research and development initiatives in nutrition therapy are further expected to open up new growth avenues for the global parenteral nutrition market in the coming years.  

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/parenteral-nutrition-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Aculife Healthcare Private Limited
  • Braun Melsungen AG
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Otsuka Pharmaceutical Factory Inc.
  • Pfizer Inc.
  • Servona GmbH

Parenteral Nutrition Market Segmentation:

Our report has categorized the market based on region, nutrient type and end use.

Breakup by Nutrient Type:

  • Carbohydrates
  • Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Trace Elements
  • Vitamins and Minerals

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us:

IMARC Group is globally recognized as a leader in market research, specializing in offering strategic management solutions and extensive market analyses across diverse industries. We collaborate with clients worldwide, focusing on identifying the most lucrative opportunities, addressing critical business challenges, and guiding significant business transformations.

Our detailed reports cover significant market, scientific, economic, and technological developments, serving business leaders in pharmaceutical, industrial, and high technology sectors. With a deep expertise in providing industry forecasts and analyses for sectors including biotechnology, advanced materials, pharmaceuticals, and food and beverage, we equip leaders with the knowledge to navigate complex markets and stay ahead of technological trends.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations